TLSI
TriSalus Life Sciences Surges Ahead with Record-Breaking Q2 2026 Results
TriSalus Life Sciences, a leading developer of innovative cancer treatment solutions, has posted impressive second-quarter (Q2) 2026 financial results. In a recent conference call, the company's leadership team shared details of their growth and strategic initiatives. According to Mary Szela, President and Chief Executive Officer, TriSalus achieved total